CXCL8 and esophageal cancer: In esophageal cancer cells or cancer stem cells, metformin reversed the expression of several inflammatory genes, including IL-8, Lin28B, Let-7, IL-1α, IL-1β, IL-1, and vascular endothelial growth factor (VEGF), preventing cellular proliferation and transformation36,37.